SCHEMBL24494691

SCHEMBL24494691

CC(c1oc(=O)c2ccccc2c1-c1cccc([C@H]2CCCN2)c1)n1nc(I)c2c(N)ncnc21

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PIK3CD O00329 15/20 0.41
▸ PIK3CG P48736 9/20 0.39
▸ PIK3R1 P27986 1/20 0.39
▸ CSNK1E P49674 1/20 0.39
▸ PIK3CA P42336 6/20 0.34
▸ ABL1 P00519 5/20 0.34
▸ SRC P12931 5/20 0.34
▸ PIK3CB P42338 5/20 0.34
▸ EGFR P00533 5/20 0.34
▸ HCK P08631 4/20 0.34
▸ KDR P35968 4/20 0.34
▸ MTOR P42345 4/20 0.34
▸ EPHB4 P54760 4/20 0.34
▸ PRKDC P78527 4/20 0.34
▸ PI4KB Q9UBF8 4/20 0.34
▸ RET P07949 1/20 0.33
▸ BTK Q06187 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22504952 1.00 PIK3CD (0.41) PIK3CDPIK3CGPIK3R1CSNK1EPIK3CA
Hydrochloric Acid SCHEMBL30679720 0.99 PIK3CD (0.40) PIK3CDPIK3CGPIK3R1CSNK1EPIK3CA
Hydrochloric Acid SCHEMBL22498182 0.99 PIK3CD (0.40) PIK3CDPIK3CGPIK3R1CSNK1EPIK3CA
SCHEMBL22504993 0.86 PIK3CD (0.41) PIK3CDPIK3CGPIK3R1CSNK1EPIK3CA
SCHEMBL30679714 0.86 PIK3CD (0.41) PIK3CDPIK3CGPIK3R1CSNK1EPIK3CA
SCHEMBL24494704 0.86 PIK3CD (0.41) PIK3CDPIK3CGPIK3R1CSNK1EPIK3CA
SCHEMBL16783796 0.84 PIK3CD (0.42) PIK3CDPIK3CGPIK3R1CSNK1EPIK3CA
SCHEMBL16783451 0.83 SRC (0.48) PIK3CDPIK3CGPIK3R1CSNK1EPIK3CA
SCHEMBL16783414 0.83 PIK3CD (0.44) PIK3CDPIK3CGPIK3R1CSNK1EPIK3CA
SCHEMBL22504971 0.81 PIK3CD (0.44) PIK3CDPIK3CGPIK3R1CSNK1EPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220175784-A1 ISOCHROMENE DERIVATIVES AS PHOSPHOINOSITIDE 3-KINASES INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2022-06-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220175784-A1 ISOCHROMENE DERIVATIVES AS PHOSPHOINOSITIDE 3-KINASES INHIBITORS PIKFYVE, PDPK1, PIK3R5 PIK3CD 5/4885PIK3CG 13/4885PIK3R1 19/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback